Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (11): 1161-1162.DOI: 10.3969/j.issn.1673-8640.2015.11.023
• Orginal Article • Previous Articles
Received:2015-01-13
Online:2015-11-30
Published:2015-12-03
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.11.023
| 组别 | 例数 | BAP(U/L) | 血钙(mmol/L) |
|---|---|---|---|
| 妊娠早期组 | 185 | 153±19 | 2.30±0.28 |
| 妊娠中期组 | 210 | 161±24 | 2.23±0.27 |
| 妊娠晚期组 | 232 | 183±27 | 1.85±0.22 |
| 正常对照组 | 258 | 138±25 | 2.32±0.30 |
| 组别 | 例数 | BAP(U/L) | 血钙(mmol/L) |
|---|---|---|---|
| 妊娠早期组 | 185 | 153±19 | 2.30±0.28 |
| 妊娠中期组 | 210 | 161±24 | 2.23±0.27 |
| 妊娠晚期组 | 232 | 183±27 | 1.85±0.22 |
| 正常对照组 | 258 | 138±25 | 2.32±0.30 |
| 组别 | 例数 | <150 U/L | 150~200 U/L | >200 U/L |
|---|---|---|---|---|
| 妊娠早期组 | 185 | 143(77.3) | 36(19.5) | 6(3.8) |
| 妊娠中期组 | 210 | 154(73.3) | 45(21.4) | 11(5.2) |
| 妊娠晚期组 | 232 | 158(68.1) | 61(26.3) | 13(5.6) |
| 正常对照组 | 258 | 227(88.0) | 28(10.9) | 3(1.1) |
| 组别 | 例数 | <150 U/L | 150~200 U/L | >200 U/L |
|---|---|---|---|---|
| 妊娠早期组 | 185 | 143(77.3) | 36(19.5) | 6(3.8) |
| 妊娠中期组 | 210 | 154(73.3) | 45(21.4) | 11(5.2) |
| 妊娠晚期组 | 232 | 158(68.1) | 61(26.3) | 13(5.6) |
| 正常对照组 | 258 | 227(88.0) | 28(10.9) | 3(1.1) |
| [1] | 易伟莲,廖德权,林柏云,等. 绝经后骨质疏松症患者性激素、细胞因子及骨代谢指标的变化及关系[J]. 检验医学,2012,27(4):296-298. |
| [2] | ROSS PD, KRESS BC, PARSON RE,et al.Serum bone alkaline phosphatase and calcaneus bone density predict fractures:a prospective study[J].Osteoporos Int,2000,11(1):76-82. |
| [3] | 袁敏敏,宋美芳,高怡.骨代谢生化指标测定在妇科临床中的应用价值[J].中华检验医学杂志,2001,24(1):16-18. |
| [4] | 徐定英,叶玲玲,周霁.海岛孕妇骨密度测定分析[J].现代中西医结合杂志,2005,14(18):2424. |
| [5] | 吴楠,刘敏,王宏志.孕妇血清中钙、磷、碱性磷酸酶与全血骨碱性磷酸酶检测结果分析[J].中国妇幼保健,2006,21(6):831-832. |
| [6] | 张峰,马扬.骨碱性磷酸酶与骨密度相关性分析[J].中国妇幼保健,2011,26(31):4865-4866. |
| [7] | 刘颖,冯宁.成人型骨碱性磷酸酶与血钙联合检测在孕妇钙营养评价中的价值[J].中国妇幼保健,2010,25(16):2295-2296. |
| [8] | 陈小舟. 892例正常孕妇的碱性磷酸酶结果分析及探讨[J].中国实用医药,2011,6(29):99-100. |
| [9] | 孙海丽,胡嫦,吴玲.孕期微量元素钙铁值测定结果临床分析[J].中国妇幼保健,2012,27(30):4705-4706. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
